PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34592904-2	2021	To start with, the network pharmacology approach and molecular docking technology were used to uncover all candidate targets of oxyresveratrol to treat liver cancer, accompanied with identified anti-liver cancer targets including estrogen receptor 1 (ESR1), epidermal growth factor receptor (EGFR).	puag-haad	128-142	estrogen receptor 1	Homo sapiens	230-249	
34592904-2	2021	To start with, the network pharmacology approach and molecular docking technology were used to uncover all candidate targets of oxyresveratrol to treat liver cancer, accompanied with identified anti-liver cancer targets including estrogen receptor 1 (ESR1), epidermal growth factor receptor (EGFR).	puag-haad	128-142	estrogen receptor 1	Homo sapiens	251-255	
34592904-5	2021	The in-vitro data indicated that intracellular contents of ESR1, EGFR mRNAs in oxyresveratrol-treated liver cancer cells were reduced.	puag-haad	79-93	estrogen receptor 1	Homo sapiens	59-63	
28484893-0	2017	Oxyresveratrol Is a Phytoestrogen Exerting Anti-inflammatory Effects Through NF-kappaB and Estrogen Receptor Signaling.	puag-haad	0-14	estrogen receptor 1	Homo sapiens	91-108	
28484893-3	2017	In MCF-7 cells, oxyresveratrol significantly induced proliferation, which was accompanied with estrogen receptor (ER)-mediated transcriptional activation, increased estrogen-targeted gene expression (e.g., pS2, PGR, and CTSD), and increased ERalpha/beta proteins.	puag-haad	16-30	estrogen receptor 1	Homo sapiens	95-112	
28484893-3	2017	In MCF-7 cells, oxyresveratrol significantly induced proliferation, which was accompanied with estrogen receptor (ER)-mediated transcriptional activation, increased estrogen-targeted gene expression (e.g., pS2, PGR, and CTSD), and increased ERalpha/beta proteins.	puag-haad	16-30	estrogen receptor 1	Homo sapiens	114-116	
28484893-4	2017	The estrogen-like effect of oxyresveratrol was reversed by the ER inhibitor ICI 182780.	puag-haad	28-42	estrogen receptor 1	Homo sapiens	63-65	
28484893-5	2017	Strong ER-binding activities of oxyresveratrol were revealed by negative docking scores.	puag-haad	32-46	estrogen receptor 1	Homo sapiens	7-9